166 related articles for article (PubMed ID: 19696530)
1. Disappointing recent cholesterol-lowering drug trials: is it not time for a full reappraisal of the cholesterol theory?
de Lorgeril M
World Rev Nutr Diet; 2009; 100():80-89. PubMed ID: 19696530
[No Abstract] [Full Text] [Related]
2. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
[No Abstract] [Full Text] [Related]
3. Is there a problem with ezetimibe or just ENHANCEd hype?
Whayne TF
Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
[No Abstract] [Full Text] [Related]
4. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
Catapano AL; Davidson MH; Ballantyne CM; Brady WE; Gazzara RA; Tomassini JE; Tershakovec AM
Curr Med Res Opin; 2006 Oct; 22(10):2041-53. PubMed ID: 17022864
[TBL] [Abstract][Full Text] [Related]
5. Ezetimibe/simvastatin single tablet versus rosuvastatin in patients with hypercholesterolemia.
Daskalopoulou SS; Mikhailidis DP
Curr Med Res Opin; 2006 Oct; 22(10):2037-9. PubMed ID: 17022863
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol lowering, cardiovascular diseases, and the rosuvastatin-JUPITER controversy: a critical reappraisal.
de Lorgeril M; Salen P; Abramson J; Dodin S; Hamazaki T; Kostucki W; Okuyama H; Pavy B; Rabaeus M
Arch Intern Med; 2010 Jun; 170(12):1032-6. PubMed ID: 20585068
[TBL] [Abstract][Full Text] [Related]
7. ENHANCE results: a surrogate trial that impacts beyond size and scope.
Cardiovasc J Afr; 2008; 19(3):166-8. PubMed ID: 18568183
[No Abstract] [Full Text] [Related]
8. Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared to rosuvastatin 10 mg in high-risk patients with and without type 2 diabetes mellitus inadequately controlled despite prior statin monotherapy.
Vaverkova H; Farnier M; Averna M; Missault L; Viigimaa M; Dong Q; Shah A; Johnson-Levonas AO; Brudi P
Cardiovasc Ther; 2012 Apr; 30(2):61-74. PubMed ID: 20626402
[TBL] [Abstract][Full Text] [Related]
9. Heterozygous familial hypercholesterolemia case study.
Friedrich DA
J Am Acad Nurse Pract; 2010 Oct; 22(10):523-6. PubMed ID: 21040085
[TBL] [Abstract][Full Text] [Related]
10. In brief: Zetia and Vytorin: the ENHANCE study.
Med Lett Drugs Ther; 2008 Jan; 50(1278):5. PubMed ID: 18219263
[No Abstract] [Full Text] [Related]
11. Use of once-weekly statin in combination with ezetimibe in a patient with mitochondrial disease.
Li M; Al-Sarraf A; Mattman A; Frohlich J
BMJ Case Rep; 2012 Apr; 2012():. PubMed ID: 22604766
[TBL] [Abstract][Full Text] [Related]
12. New developments in pharmacotherapy.
Thompson GR
Cardiovasc J S Afr; 2004; 15(2):56-8. PubMed ID: 15148538
[No Abstract] [Full Text] [Related]
13. [On the current debate on lowering LDL cholesterol with ezetimibe].
Schunn H
Dtsch Med Wochenschr; 2010 Nov; 135(44):2202; author reply 2202. PubMed ID: 20979010
[No Abstract] [Full Text] [Related]
14. Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials.
Catapano A; Brady WE; King TR; Palmisano J
Curr Med Res Opin; 2005 Jul; 21(7):1123-30. PubMed ID: 16004682
[TBL] [Abstract][Full Text] [Related]
15. Newer pharmaceutical agents to treat lipid disorders.
Davidson MH
Curr Cardiol Rep; 2003 Nov; 5(6):463-9. PubMed ID: 14558988
[TBL] [Abstract][Full Text] [Related]
16. [60% of patients with coronary disease receive antilipemic drugs. Nevertheless cholesterol often is too high].
MMW Fortschr Med; 2001 Nov; 143(44):60. PubMed ID: 11732408
[No Abstract] [Full Text] [Related]
17. [Drug of the month. Ezetimibe/simvastatin tablet (Inegy)].
Scheen AJ; Radermecker RP
Rev Med Liege; 2007 Sep; 62(9):585-90. PubMed ID: 17966796
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP
Int Angiol; 2011 Jun; 30(3):295; author reply 296. PubMed ID: 21617615
[No Abstract] [Full Text] [Related]
19. After ENHANCE: is more LDL cholesterol lowering even better?
Stein EA
Clin Chem; 2008 Jun; 54(6):940-2. PubMed ID: 18403568
[No Abstract] [Full Text] [Related]
20. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]